Pyxis Oncology, Inc. SEC filings PYXS
Pyxis Oncology, Inc. has 356 filings in SEC EDGAR's recent list, going back to Jul 12, 2019. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Oct 1, 2026 | — |
| 424B5 | Prospectus supplement | Sep 29, 2026 | — |
| 424B5 | Prospectus supplement | Sep 29, 2026 | — |
| 424B2 | Prospectus | Aug 28, 2026 | — |
| S-3 | Shelf registration | Aug 20, 2026 | — |
| S-8 | Employee stock plan registration | Mar 23, 2026 | — |
| S-3 | Shelf registration | Nov 26, 2025 | — |
| S-8 | Employee stock plan registration | Mar 18, 2025 | — |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| 424B2 | Prospectus | Apr 4, 2024 | — |
| S-3 | Shelf registration | Mar 27, 2024 | — |
| S-8 | Employee stock plan registration | Mar 22, 2024 | — |
| S-8 POS | Form s-8 pos | Aug 23, 2023 | — |
| POS AM | Form pos am | Aug 23, 2023 | — |
| S-8 | Employee stock plan registration | Aug 23, 2023 | — |
| 424B3 | Prospectus | Jun 30, 2023 | — |
| S-4/A | Form s-4/a | Jun 29, 2023 | — |
| S-4 | Registration for a merger or exchange | Jun 8, 2023 | — |
| S-8 | Employee stock plan registration | Mar 22, 2023 | — |
| S-3 | Shelf registration | Nov 1, 2022 | — |
| S-8 | Employee stock plan registration | Jul 1, 2022 | — |
| S-8 | Employee stock plan registration | Mar 29, 2022 | — |
| S-8 | Employee stock plan registration | Oct 22, 2021 | — |
| 424B4 | Prospectus | Oct 8, 2021 | — |
| S-1MEF | Filing | Oct 7, 2021 | — |
| S-1/A | Amended registration statement | Oct 7, 2021 | — |
| S-1/A | Amended registration statement | Oct 4, 2021 | — |
| S-1/A | Amended registration statement | Oct 1, 2021 | — |
| S-1 | Registration statement | Sep 17, 2021 | — |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PYXS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1782223
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.